Inventor
Michael C. Venuti
Inventor
San Francisco, CA, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
C07CAcyclic or carbocyclic compounds29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
A61KPreparations for medical, dental or toiletry purposes10%
C07KPeptides8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
6,171,578'Benzodiazepine derivatives for imaging thrombi'20015,876,970'Surfactant compositions and methods'19995,155,132'Naphthalene lipoxygenase-inhibiting agents'19925,134,161'Method for treating disease states in mammals with naphthalene lipoxygenase-inhibiting agents'19925,091,558'Naphthalene anti-psoriatic agents'19925,089,657'Naphthalene anti-psoriatic agents'19924,970,297'Transglutaminase inhibitors'19904,946,845'Naphthalene anti-psoriatic agents'19904,929,630'Transglutaminase inhibitors'19904,912,120'3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitors'19904,840,965'Naphthalene anti-psoriatic agents'19894,792,556'Naphthalene anti-psoriatic agents'19884,786,652'Naphthalene anti-psoriatic agents'19884,761,416'N-N-disubstituted-.omega.-[2-amino-3-(carbonylmethyl)-3, 4-dihydroquinazolinyl]oxyalkylamides and related compounds'19884,758,587'Naphthalene anti-psoriatic agents'19884,739,056'N-N-disubstituted-omega-(2-amino-3-(carbonylmethyl)-3,4-dihy droquinazolinyl)oxy-alkylamides and related compounds'19884,690,925'(2-Oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl) oxyalkylamides properties having phosphodiosterase inhibiting'19874,670,434'(2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]q uinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors'19874,663,320'(2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof'19874,593,120'Naphthalene anti-psoriatic agents'19864,593,029'Novel .omega.-(N-imidazolyl)alkyl ethers of 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones'19864,551,459'Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-b]quinazolinyl)oxyalkylamides'19854,490,371'N,N-Di substituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkyl amides'19844,466,981'Naphthalene anti-psoriatic agents'19844,296,042'Preparation of unsaturated aliphatic insect pheromones using cyclic phosphonium ylids'1981Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1981–1992Patents assigned to SYNTEX INC (23)· patent assignee history
1981–2001Based in San Francisco, CA, US· patent location history
1999Patents assigned to BYK GULDEN LOMBERG CHEM FAB (1)· patent assignee history
2001Patents assigned to DIATIDE INC (1)· patent assignee history
2001Patents assigned to GENENTECH INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SYNTEX INC | 23 | 1981–1992 |
| BYK GULDEN LOMBERG CHEM FAB | 1 | 1999 |
| DIATIDE INC | 1 | 2001 |
| GENENTECH INC | 1 | 2001 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 25 | 1981–2001 |